Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01616
Species: Homo sapiens
Position : chr5:171390000-171400000
Year: 2024
Title: Super-enhancer-driven FOSL1-TCOF1 axis promotes triple-negative breast cancer progression
Genome Build: hg38
Enhancer Type: Super-enhancer
Condition: Disease
Disease Name: breast carcinoma
PMID:  39012147
MONDO: MONDO:0006120
Tissue: Breast
Tissue Ontology ID: UBERON:0000310
Cell Source: MDA-MB-231
CVCL ID: CVCL_0062
Cell Type: breast carcinoma cell
Cell Ontology ID: CL:0000646
Experiment Type: Enhancer activity assay, TF binding assay, Functional perturbation assay
High Throughput Method: ChIP-seq, RNA-seq
Low Throughput Method: Luciferase Reporter Assay, ChIP-RT-qPCR, qRT-PCR, Western blot
About Target Gene
Target gene : TCOF1
About TF
TF name : FOSL1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
FOSL1 AP-1 transcription factor network pid 71
FOSL1 Calcineurin-regulated NFAT-dependent transcription in lymphocytes pid 50
FOSL1 Calcium signaling in the CD4+ TCR pathway pid 29
FOSL1 Downstream signaling in naïve CD8+ T cells pid 69
FOSL1 Gene expression of IL2 by AP-1 ( CD4 T cell receptor signaling (JNK cascade) ) inoh 5
FOSL1 Gene expression of IL2 by AP-1 ( CD4 T cell receptor signaling ) inoh 5
FOSL1 JNK cascade ( CD4 T cell receptor signaling (JNK cascade) ) inoh 12
FOSL1 JNK cascade ( CD4 T cell receptor signaling ) inoh 10
FOSL1 TGF-beta signaling pathway panther 88
FOSL1 Validated targets of C-MYC transcriptional activation pid 80
FOSL1 Validated transcriptional targets of AP1 family members Fra1 and Fra2 pid 37
FOSL1 Wnt signaling pathway kegg 135
Enhancer Associated Network
Overlapping Enhancers (hg38)
No overlapping enhancers found in hg38 at this locus.
Expression of Target Genes for the Enhancer